麻豆传媒

The next week on advancing treatments for post-traumatic stress disorder.

Female doctors have an compared with their counterparts in the general population, a 20-country meta-analysis found. (The BMJ)

The Atlantic examined the .

In a phase II dose-finding study of adults with schizophrenia, the lowest dose of an investigational muscarinic M4 selective agonist significantly reduced scores on the versus placebo, Neurocrine Biosciences said.

ProPublica did a deep dive into .

Kentucky is unnecessarily housing patients with and violating the Americans with Disabilities Act in doing so, the Justice Department alleged.

While investigational xanamem to meet its primary goal in a placebo-controlled phase IIa trial of patients with cognitive dysfunction and major depressive disorder, developer Actinogen Medical said the drug for the secondary outcome of depression scores in the subgroup with baseline cognitive impairment.

is trending -- but what is it? (Forbes)

Inflammatory biomarkers -- including leukocytes, haptoglobin, C-reactive protein, and immunoglobulin G -- were linked with a heightened risk of , a cohort study indicated. (JAMA Psychiatry)

The Surgeon General issued an advisory urging and well-being of parents and caregivers.

More than 500 therapists told ProPublica about that led them to go out-of-network.

Epic Research data found that older adults with diabetes were more likely to have average HbA1c values under 6.5% or over 8% in the 5 years prior to the diagnosis compared with diabetic patients without Alzheimer's.

Rep. Yadira Caraveo, MD (D-Colo.), said she had and is speaking out in order to help destigmatize mental illness. (NBC News)

Comment